BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Piramal Healthcare Limited in Talks to Buy US Contract Drug Maker Cambridge Major Laboratories, Inc. for $200 Million


6/19/2012 7:37:16 AM

Piramal Healthcare (PHL) is in talks to buy US contract drug manufacturer Cambridge Major Laboratories (CML) for around $200 million, a person with direct knowledge of the development said. “Early stage negotiations are on and it will take a while to conclude the deal,” he said. PHL is the flagship company of the Ajay Piramal-owned Piramal Group while the Wisconsin-based unlisted CML makes pharmaceutical intermediates and active pharmaceutical ingredients (APIs) used in drugs. The company is a global chemistry outsourcing partner to pharmaceutical and biotechnology companies, owning three facilities in US and one in Europe.

Read at Financial Express
Read at Money Control
Read at News Release


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->